These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6776767)

  • 21. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
    Visani G; Finelli C; Castelli U; Petti MC; Ricci P; Vianelli N; Gianni L; Zuffa E; Aloe Spiriti MA; Latagliata R
    Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postpolycythemia myeloid metaplasia.
    Silverstein MN
    Arch Intern Med; 1974 Jul; 134(1):113-7. PubMed ID: 4833938
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis.
    Rondeau E; Solal-Celigny P; Dhermy D; Vroclans M; Brousse N; Bernard JF; Boivin P
    Br J Haematol; 1983 Mar; 53(3):467-75. PubMed ID: 6824588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splenectomy in agnogenic myeloid metaplasia.
    Porcu P; Neiman RS; Orazi A
    Blood; 1999 Mar; 93(6):2132-4. PubMed ID: 10189205
    [No Abstract]   [Full Text] [Related]  

  • 25. Splenectomy for agnogenic myeloid metaplasia.
    Gomes MR; Silverstein MN; Remine WH
    Surg Gynecol Obstet; 1967 Jul; 125(1):106-8. PubMed ID: 6026679
    [No Abstract]   [Full Text] [Related]  

  • 26. Spontaneous remission of agnogenic myeloid metaplasia in a splenectomized patient: a case report with erythrokinetic studies.
    Shimizu K; Hotta T
    Acta Haematol; 1990; 83(1):45-8. PubMed ID: 2105570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agnogenic myeloid metaplasia: role of splenectomy.
    Marks C; Ahmadi M
    Postgrad Med J; 1969 Apr; 45(522):261-5. PubMed ID: 5821186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.
    Dupriez B; Morel P; Demory JL; Lai JL; Simon M; Plantier I; Bauters F
    Blood; 1996 Aug; 88(3):1013-8. PubMed ID: 8704209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agnogenic myeloid metaplasia with pulmonary hematopoiesis.
    Boula A; Mantadakis E; Xilouri I; Foudoulakis A; Samonis G
    Hematology; 2005 Dec; 10(6):501-3. PubMed ID: 16321815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agnogenic myeloid metaplasia of the spleen; follow-up after splenectomy.
    SKINNER HL; SOPHIAN LJ
    J Int Coll Surg; 1951 Mar; 15(3):343-6. PubMed ID: 14824588
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report.
    Sullivan A; Rheinlander H; Weintraub LR
    Gastroenterology; 1974 Mar; 66(3):429-32. PubMed ID: 4813509
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ
    Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe post-splenectomy hepatic insufficiency in a patient with agnogenic myeloid metaplasia].
    Pérez-Villa F; Font J; Feliu E; Campo E; Ingelmo M
    Med Clin (Barc); 1988 Jun; 91(3):108-10. PubMed ID: 3172909
    [No Abstract]   [Full Text] [Related]  

  • 35. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.
    Barosi G; Ambrosetti A; Centra A; Falcone A; Finelli C; Foa P; Grossi A; Guarnone R; Rupoli S; Luciano L; Petti MC; Pogliani E; Russo D; Ruggeri M; Quaglini S
    Blood; 1998 May; 91(10):3630-6. PubMed ID: 9572998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A; Lottenberg R; Griffith R; Reinhard E
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between autoimmunity and agnogenic myeloid metaplasia.
    Ben-Chetrit E; Gross DJ; Okon E; Levo Y
    Scand J Haematol; 1983 Nov; 31(5):410-2. PubMed ID: 6606213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postsplenectomy pericardial effusion in two patients with myeloid metaplasia.
    Nagler A; Brenner B; Argov S; Tatarsky I
    Arch Intern Med; 1986 Mar; 146(3):600-1. PubMed ID: 3954534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
    Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
    Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agnogenic myeloid metaplasia; its current managment.
    Silverstein MN
    Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.